ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
10.50
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST

ME Therapeutics Holdings Cash Flow Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Nov '24 Aug '24 Aug '23 Aug '22
Net Income
-1.25-1.29-6.52-0.15
Depreciation & Amortization
0.01000
Stock-Based Compensation
0.640.70.620.01
Other Operating Activities
0-5.550.01
Change in Accounts Payable
0.05-0.060.06-0
Change in Other Net Operating Assets
0.01-0-0.02-0.01
Operating Cash Flow
-0.54-0.66-0.3-0.14
Cash Acquisitions
--0.76-
Investing Cash Flow
-0.02-0.76-
Short-Term Debt Issued
---0.14
Total Debt Issued
---0.14
Short-Term Debt Repaid
--0.04--
Total Debt Repaid
-0.05-0.04--
Net Debt Issued (Repaid)
-0.05-0.04-0.14
Issuance of Common Stock
1.561.560.12-
Other Financing Activities
-0.01-0.01--
Financing Cash Flow
1.51.510.120.14
Net Cash Flow
0.940.850.570
Levered Free Cash Flow
-0.12-0.220.07-
Unlevered Free Cash Flow
-0.12-0.220.08-
Change in Net Working Capital
-0.060.06-0.07-
Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.